Expression of the human NOV gene in first trimester fetal tissues |
| |
Authors: | Sylvia Kocialkowski Herman Yeger John Kingdom Bernard Perbal P. N. Schofield |
| |
Affiliation: | Laboratory of Stem Cell Biology, Department of Anatomy, University of Cambridge, Downing Street, Cambridge, CB2 3DY, UK e-mail: PS@ mole.bio.cam.ac.uk Tel.: +44-1223-333893, Fax: 44-1223-333786, GB Department of Pathology, Hospital for Sick Children and University of Toronto, Toronto, Canada, CA Maternal-Fetal Medicine, Mount Sinai Hospital, Suite 775B, University of Toronto, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5, CA Laboratoire d’Oncologie Virale et Moleculaire, UFR de Biochimie, Université Paris 7, D. Diderot, 75005 Paris, France, FR
|
| |
Abstract: | NOV, located on human chromosome 8q24.1, was originally cloned following discovery of its avian homolog as a consequence of over-expression in virally induced nephroblastoma. The gene product is a secreted, modular, protein and a member of the CCN gene family. Evidence to date indicates that the expression of the wild type protein is associated with cellular quiescence in normal embryonic fibroblasts yet produces growth stimulatory effects on established murine NIH 3T3 cells. Here we report the expression of NOV in the first trimester of human embryogenesis, between 5 and 10 weeks. In situ hybridisation and immunohistochemistry reveal widespread expression in derivatives of all three germ layers. The most abundant sites of expression are in the motor neurons and floor plate of the spinal cord, adrenal cortex, fusing skeletal, and smooth muscle, the urogenital system and the developing heart. Additionally, expression is seen in the cranial ganglia, differentiating chondrocytes, gonads, and lung. The sites of expression suggest strongly that autocrine or paracrine expression of NOV is associated with the process of cell differentiation. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|